08:59 AM EDT, 06/18/2025 (MT Newswires) -- Fractyl Health ( GUTS ) said Wednesday that the US Patent and Trademark Office has granted two new patents related to duodenal resurfacing applications.
The two patents are directed to ablating duodenal mucosa with electrical energy, including thermal and non-thermal, the company said.
Fractyl said its intellectual property portfolio now includes 31 granted US patents and around 40 pending US applications, along with foreign-issued patents and pending applications.